Search PubMed⌕ Search

Biomedical subjects

P Robinson

Publications and source records attributed to P Robinson.

At least 307 records · Page 17Linked to original sources

Characterization of antigens on murine tumor cells reacting with alloantisera against foreign H-2 specificities: analysis by absorption with purified murine leukemia virus and normal lymphoid cells of different H-2 haplotypes.

A spontaneous T cell lymphoma of DBA/2 (H-2-d) mice, SL2, was found to react with anti H-2 typing sera raised against certain foreign haplotypes as well as with anti H-2d sera. The cytotoxic anti-SL2 activity of the anti-foreign H-2 sera was detected in a newly developed microradioassay, not however, in a conventional 51Cr release test. Upon culture in vitro the reactivity of the tumor cells with the anti H-2 sera decreased. The anomalous cytotoxic anti-tumor activity of the anti-foreign H-2 sera appeared to be distinct from anti-murine leukemia virus activity, since it was not removed by absorption with either Friend of AKR leukemia virus. Partial absorption was observed with normal lymphoid cells carrying the respective foreign H-2 antigens, but not with cells of unrelated H-2 haplotypes. In each serum tested, the anti-tumor activity could also be absorbed with syngeneic H-2d lymphoid cells. These results show that the anomalous anti-tumor reactivity of certain anti H-2 typing sera, in particular of sera raised in recipients differing in H-2 from the tumor host strains, is not due to the presence of foreign (derepressed) H-2 molecules on the tumor cells. The differences observed between the tumor cells and normal cells seem to be due to unexpected antibodies in the sera reacting with public H-2 specificities which are better exposed on the tumor cells than on normal cells.

Absorption↗

A preliminary characterization of human cementum collagen.

Human teeth were used to obtain cementum. Collagen could not be significantly solubilized from the cementum by salt and acetic acid extraction or by pepsin digestion. CNBr digestion (86%) of cementum and subsequent carboxymethyl cellulose chromatography suggests that human cementum consists of type I collagen only as identified by amino acid and hexose analyses.

Amino Acids↗

Isolation of chlorophenoxy herbicides on columns of glass beads.

A method for the analysis of chlorophenoxy herbicide residues has been developed based on the observed adsorptive affinity of chlorophenoxy acids for glass surfaces. Extracted residues of 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) herbicides are adsorbed onto a column of fine mesh glass beads, and subsequently esterified with diazomethane for gas-liquid chromatographic quantitation, using an electron capture detector. Prior to injection, the esterified sample is cleaned up by passing through a Florisil column. The method is sensitive to about 0.5 ppm 2,4-D and 0.01 ppm 2,4,5-T. Recoveries averaged from 81 to 101%, depending on the level added and the substrate.

2,4,5-Trichlorophenoxyacetic Acid↗

New apparatus for measuring forces in strabismus.

An apparatus for measuring muscle forces in strabismus has been developed. The globe is fixed with a modified suction cup, force applied is measured by strain gauges, and the excursion of the globe is measured by a light pointer and tangent screen. The values of force generation tests for normal horizontal rectus muscles performing 30 degrees saccades lie mainly within the range of 60 to 80 G.

Eye Movements↗

Group C beta-hemolytic streptococcal endocarditis: report of a pediatric case.

A 9-year-old boy with a ventricular septal defect and a bicuspid aortic valve developed bacterial endocarditis due to group C streptococci. He responded to an initial antibiotic regimen of nafcillin plus gentamicin and was cured by the use of penicillin G following the isolation of the organism. The unusual nature of this case is discussed and physicians are cautioned to recognize this organism as a potential cause of infectious endocarditis in the pediatric population.

Aortic Valve↗

Prenatal cocaine treatment reduces haloperidol-induced catalepsy on postnatal day 10.

This study examined the influence of prenatal cocaine on subsequent cataleptic responses to the dopamine (DA) receptor antagonist haloperidol. Pregnant Sprague-Dawley rats were given daily injections of 40 mg/kg cocaine HCl SC from gestational day 8 to 20. Control animals were either uninjected and fed ad lib or saline-injected and pair-fed to the cocaine dams. On postnatal day (PD) 1, litters were culled to eight (sex-balanced if possible) and fostered to surrogate mothers. On PD 10 and PD 15, one male and one female from each litter were injected SC with 1 mg/kg haloperidol or vehicle. Each pup was tested for catalepsy 1 h later by placing its forepaws on an elevated, horizontally oriented dowel rod and recording the latency to remove at least one paw from the dowel. On PD 10 but not PD 15, haloperidol administration produced significantly less catalepsy in the cocaine-exposed subjects than in the untreated controls. No other group differences were observed. These results suggest that prenatal cocaine may alter either the DA system or any of several other neurotransmitters known to influence neuroleptic-induced catalepsy.

Animals↗

Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection.

Nevirapine (NVP) is a nonnucleoside reverse transcriptase inhibitor widely used in combination with other antiretroviral agents for the treatment of human immunodeficiency virus disease. To establish its safety profile, we conducted a review of data from prospective US and international clinical trials involving a total of 906 adult patients and 468 pediatric patients treated with NVP. Drug-related adverse events were similar in adults and children, with rash and nausea most frequently reported in adults and rash and granulocytopenia most frequently reported in children. A separate analysis of rash based on data from adult patients in controlled trials demonstrated a 16% rate of NVP-attributable rash in these patients. Of patients with NVP-associated rash, 65% developed rash within the first 6 weeks of therapy, and it has been shown that a lower lead-in dose (200 mg/d vs the standard 400 mg/d) for the first 2 weeks of NVP treatment reduces the frequency of drug-associated rash. Serious rash (Stevens-Johnson syndrome [SJS] or SJS/toxic epidermal necrolysis transition syndrome) occurred with an incidence of 0.3% and clinical hepatitis with an incidence of 1.0% among NVP-treated patients in clinical trials. Adverse event data from long-term clinical trials demonstrated a lower incidence of NVP-related adverse events than in short-term trials of NVP therapy. An analysis of abnormal laboratory findings using thresholds similar to those found in the prescribing information for other commonly used antiretroviral agents and data from controlled trials in adults showed that the most frequently observed laboratory abnormalities were elevations in liver function test results. Approximately 50,000 patients in the United States had been treated with marketed NVP at the time of writing, and postmarketing surveillance has supported the overall safety profile observed in clinical trials. NVP has been shown to be well tolerated in both adult and pediatric patients.

Adolescent↗